Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Dr.-Dhananjay-Kumar-Tiwary"

1 News Found

Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
People | June 22, 2026

Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC

Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies

Upcoming E-conference
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla

MICK Digital empanelled as AMTZ authorized channel partner

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
Dr. Manjiri Bakre CEO and Founder, OncoStem Diagnostics
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
Akhil Ravi Chief Executive Officer, Aurigene Pharmaceutical Services Limited

Packaging